Featured
Peer-Reviewed Publication: Integrative Framework for Thyroid & Endocrine Resilience
Homocysteine and Thyroid Disease: Making the Connection
Homocysteine is generated during methionine metabolism as part of one-carbon and methylation pathways. When those pathways are strained, homocysteine can accumulate, which is often correlated with thyroid disease. Elevated homocysteine in individuals with thyroid dysfunction, homocysteine may signal several imbalances in the body such as increased methylation demand, metabolic slowing or inflammatory stress affecting hormone activation at the tissue level [1]. Homocysteine levels can provide insight into the broader metabolic context in which thyroid dysfunction develops and persist
Read now
Anti-depressant Non-Response: Why They Sometimes Fall Short
For many individuals with depression, antidepressant medications lead to meaningful improvement. For others, symptoms persist despite appropriate dosing and duration. This pattern is often referred to as “antidepressant non-response. New research has started to suggest that methylation should become a greater focus in an adjunctive nutritional approach in individuals who do not respond optimally to antidepressant monotherapy. There is also growing evidence that inflammatory and metabolic factors may help identify those most likely to benefit from this adjunctive approach.* [1]
Read now
L-Methylfolate and Its Role in Mood Support*
While antidepressant medications remain an important tool for many individuals, responses vary widely. For some, improvement is partial or plateaus over time, highlighting the complexity of mood biology rather than the failure of any single approach. Rather than indicating inadequacy of medication, this variability reflects the reality that mood regulation is not governed by a single pathway. When neurotransmitter signaling is supported without adequate upstream metabolic support, progress may be limited. [1] This understanding has opened the door to adjunctive approaches that focus on the biological conditions required for neurotransmitter production, not just receptor activity.
Read now
Hyperhomocysteinemia and Venous Thrombosis: Recognizing Risk Before the Event
Homocysteine is a sulfur-containing amino acid formed during the metabolism of methionine, an essential amino acid obtained from dietary protein. Under normal conditions, homocysteine is efficiently recycled through metabolic pathways that depend on folate, vitamin B12, and vitamin B6. When these pathways are disrupted, homocysteine can accumulate in circulation, resulting in hyperhomocysteinemia. [1][2] Elevated homocysteine appears to reflect a physiological environment in which vascular regulation, coagulation balance, and endothelial health may be under strain. [1]
Read now
Adrenal Failure: A Case Study of Autoimmune Polyglandular Syndrome
This case study illustrates a scenario in which hypothalamic-pituitary-adrenal (HPA) axis failure masquerades as evolving hypothalamic-pituitary-thyroid (HPT) axis dysfunction. It then discusses how treating the wrong axis first could destabilize the entire hormonal architecture.
Read now
When Hypothyroidism and Depression Persist: Could Methylfolate Be the Missing Link?
When hypothyroidism or depression are diagnosed, and a treatment plan is implemented, symptoms related to energy, mood, and cognition may continue. When these two conditions persist side by side, it often points to a deeper systems-level disconnect rather than a simple treatment failure. New findings suggest that supporting methylation pathways may enhance antidepressant response and further diminish these symptoms for some individuals.* [6]
Read now
